FDA Grants Fast-Track Designation To Cannabis Withdrawal Syndrome Drug
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
Cortez Masto helps introduce bill classifying Xylazine as a schedule 3 controlled substance
U.S. Senators Catherine Cortez Masto and Chuck Grassley (R-Iowa) have introduced a bill cracking down on the Fentanyl ...